295 related articles for article (PubMed ID: 26699087)
1. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease.
Bartneck M; Fech V; Ehling J; Govaere O; Warzecha KT; Hittatiya K; Vucur M; Gautheron J; Luedde T; Trautwein C; Lammers T; Roskams T; Jahnen-Dechent W; Tacke F
Hepatology; 2016 Apr; 63(4):1310-24. PubMed ID: 26699087
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
5. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY
J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109
[TBL] [Abstract][Full Text] [Related]
6. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.
Maina V; Sutti S; Locatelli I; Vidali M; Mombello C; Bozzola C; Albano E
Clin Sci (Lond); 2012 Jun; 122(11):545-53. PubMed ID: 22142284
[TBL] [Abstract][Full Text] [Related]
7. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
[TBL] [Abstract][Full Text] [Related]
8. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.
Heymann F; Hammerich L; Storch D; Bartneck M; Huss S; Rüsseler V; Gassler N; Lira SA; Luedde T; Trautwein C; Tacke F
Hepatology; 2012 Mar; 55(3):898-909. PubMed ID: 22031018
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.
Xu L; Chen Y; Nagashimada M; Ni Y; Zhuge F; Chen G; Li H; Pan T; Yamashita T; Mukaida N; Kaneko S; Ota T; Nagata N
Metabolism; 2021 Dec; 125():154914. PubMed ID: 34656648
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
11. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice.
Locatelli I; Sutti S; Jindal A; Vacchiano M; Bozzola C; Reutelingsperger C; Kusters D; Bena S; Parola M; Paternostro C; Bugianesi E; McArthur S; Albano E; Perretti M
Hepatology; 2014 Aug; 60(2):531-44. PubMed ID: 24668763
[TBL] [Abstract][Full Text] [Related]
12. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.
Wan J; Benkdane M; Teixeira-Clerc F; Bonnafous S; Louvet A; Lafdil F; Pecker F; Tran A; Gual P; Mallat A; Lotersztajn S; Pavoine C
Hepatology; 2014 Jan; 59(1):130-42. PubMed ID: 23832548
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
[TBL] [Abstract][Full Text] [Related]
14. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
15. Genetic deficiency in plasma protein HRG enhances tumor growth and metastasis by exacerbating immune escape and vessel abnormalization.
Tugues S; Honjo S; König C; Noguer O; Hedlund M; Botling J; Deschoemaeker S; Wenes M; Rolny C; Jahnen-Dechent W; Mazzone M; Claesson-Welsh L
Cancer Res; 2012 Apr; 72(8):1953-63. PubMed ID: 22374984
[TBL] [Abstract][Full Text] [Related]
16. PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.
Yang Y; Wu XQ; Li WX; Huang HM; Li HD; Pan XY; Li XF; Huang C; Meng XM; Zhang L; Lv XW; Wang H; Li J
Oncogene; 2018 Nov; 37(47):6119-6135. PubMed ID: 29993036
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
Matsuda M; Tsurusaki S; Miyata N; Saijou E; Okochi H; Miyajima A; Tanaka M
Hepatology; 2018 Jan; 67(1):296-312. PubMed ID: 28779552
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice.
Louvet A; Teixeira-Clerc F; Chobert MN; Deveaux V; Pavoine C; Zimmer A; Pecker F; Mallat A; Lotersztajn S
Hepatology; 2011 Oct; 54(4):1217-26. PubMed ID: 21735467
[TBL] [Abstract][Full Text] [Related]
19. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
20. Macrophage heterogeneity in liver injury and fibrosis.
Tacke F; Zimmermann HW
J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
